Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Victor H Engelhard

Showing results (51-60 of 85) with videos related to

Pageof 9
Sort By:
Cancer Immunology, Immunotherapy : CII|May 29, 2019
Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumorsKatie M Leick, Joel Pinczewski, Ileana S Mauldin, et al.
Immunology Letters|December 23, 2003
Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytesKevin T Hogan, Michael A Coppola, Christine L Gatlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastasesRenée Lengagne, Stéphanie Graff-Dubois, Marylène Garcette, et al.
Oncoimmunology|January 12, 2023
Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomasNicole L Edmonds, Sarah E Gradecki, Priya Katyal, et al.
Oncotarget|September 15, 2017
The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation statusFiyaz Mohammed, Daniel H Stones, Angela L Zarling, et al.
Journal of Reproductive Immunology|October 2, 2013
Regulatory T cells and vasectomyClaudia Rival, Karen Wheeler, Sarah Jeffrey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.
International Journal of Cancer|February 22, 2002
Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal studyFrédérique-Anne Le Gal, Armelle Prevost-Blondel, Renée Lengagne, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Cancer Immunology Research|November 4, 2017
Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell EntryAmber N Woods, Ashley L Wilson, Nithya Srivinisan, et al.
Pageof 9

Showing results (51-60 of 85) with videos related to

Sort By:
Pageof 9
Cancer Immunology, Immunotherapy : CII|May 29, 2019
Patterns of immune-cell infiltration in murine models of melanoma: roles of antigen and tissue site in creating inflamed tumorsKatie M Leick, Joel Pinczewski, Ileana S Mauldin, et al.
Immunology Letters|December 23, 2003
Identification of a shared epitope recognized by melanoma-specific, HLA-A3-restricted cytotoxic T lymphocytesKevin T Hogan, Michael A Coppola, Christine L Gatlin, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2007
Distinct role for CD8 T cells toward cutaneous tumors and visceral metastasesRenée Lengagne, Stéphanie Graff-Dubois, Marylène Garcette, et al.
Oncoimmunology|January 12, 2023
Tertiary lymphoid structures in desmoplastic melanoma have increased lymphocyte density, lymphocyte proliferation, and immune cross talk with tumor when compared to non-desmoplastic melanomasNicole L Edmonds, Sarah E Gradecki, Priya Katyal, et al.
Oncotarget|September 15, 2017
The antigenic identity of human class I MHC phosphopeptides is critically dependent upon phosphorylation statusFiyaz Mohammed, Daniel H Stones, Angela L Zarling, et al.
Journal of Reproductive Immunology|October 2, 2013
Regulatory T cells and vasectomyClaudia Rival, Karen Wheeler, Sarah Jeffrey, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|November 10, 2004
Competition among peptides in melanoma vaccines for binding to MHC moleculesLee W Thompson, Courtney F Garbee, Sarah Hibbitts, et al.
International Journal of Cancer|February 22, 2002
Lipopeptide-based melanoma cancer vaccine induced a strong MART-27-35-cytotoxic T lymphocyte response in a preclinal studyFrédérique-Anne Le Gal, Armelle Prevost-Blondel, Renée Lengagne, et al.
Advances in Immunology|May 30, 2006
Immunity to melanoma antigens: from self-tolerance to immunotherapyCraig L Slingluff, Kimberly A Chianese-Bullock, Timothy N J Bullock, et al.
Cancer Immunology Research|November 4, 2017
Differential Expression of Homing Receptor Ligands on Tumor-Associated Vasculature that Control CD8 Effector T-cell EntryAmber N Woods, Ashley L Wilson, Nithya Srivinisan, et al.
Pageof 9